RNA

ATRIUM THERAPEUTICS INC

RNA·04965N104·US·Common Stock-13D/G

RNA (ATRIUM THERAPEUTICS INC) is held by 81 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($19.5M), VANGUARD CAPITAL MANAGEMENT LLC ($9.8M), GEODE CAPITAL MANAGEMENT, LLC ($5.2M). Net institutional sentiment: Mixed.

81
Holders
(5 Elite)
$93.6M
Total Value
47% (86)
Consensus
40 buying - 46 selling
13F: Insider & Congress: Updated regularly
RNA

Smart Money Verdict

View all
Loading verdict
Held by 81 funds
5 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jan 23, 2026 · Activists Aug 14, 2026 · Congress none

ActivistRA Capital Management, L.P.RA Capital Management, L.P.0.0%Aug 14, 2026
ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.8.6%Aug 14, 2026
ActivistSISessa Capital IM, L.P.8.8%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.4M(+20.1%)$19.5M0.0%-10.84%
34
Increased
730,831(+16.6%)$9.8M0.0%-11.16%
32
Increased
386,929(+21.0%)$5.2M0.0%-10.76%
32
Increased
345,481(+93.5%)$4.6M0.0%-6.56%
43
Decreased
310,341(-11.3%)$4.2M0.0%-12.95%
0
Increased
271,762(+5.7%)$3.7M0.0%-12.28%
28
Increased
256,917(+9.0%)$3.5M0.0%-11.92%
29
Increased
200,559(+5.1%)$2.7M0.0%-12.35%
28
Increased
199,158(+22.4%)$2.7M0.0%-10.64%
32
New
172,235$2.3M0.0%+1.41%
36
Decreased
146,743(-36.6%)$2M0.0%-12.95%
0
Increased
137,394(+0.0%)$1.8M0.0%-12.95%
26
Decreased
132,833(-2.5%)$1.8M0.0%-12.95%
0
Increased
130,217(+11.7%)$1.8M0.0%-11.65%
29
Increased
129,591(+81.6%)$1.7M0.0%-7.04%
40
Increased
119,781(+21.5%)$1.6M0.0%-10.72%
31
Increased
117,275(+51.4%)$1.6M0.0%-8.55%
36
Unchanged
111,200$1.5M0.0%-12.95%
0
Increased
109,961(+15.6%)$1.5M0.0%-11.26%
29
Increased
109,810(+450.3%)$1.5M0.0%-1.54%
41

Showing 1-20 of 101

1 / 6
RNARNAATRIUM THERAPEUTICS INC

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used